ABCC3 and colorectal carcinoma: MRP3 expression has been associated with doxorubicin and etoposide resistance in several gastrointestinal cell lines, including some derived from CRC, probably through a mechanism that involves the Wnt/β-catenin signaling pathway [63,73].